MAPT and diabetes mellitus: The current research indicated that p-tau has been identified as a crucial toxic mediator in synaptic neurodegeneration of RGCs in diabetes [117]; the following will summarize how p-tau may lead to neuronal degeneration through mechanisms such as mitochondrial damage, Aβ toxicity, and inflammation, which are involved in the occurrence and development of DRN.